AGORA | European Patients’ Forum-Medicines for Europe
12012
post-template-default,single,single-post,postid-12012,single-format-standard,edgt-core-1.0,ajax_fade,page_not_loaded,,hudson child-child-ver-1.0.0,hudson-ver-1.9,vertical_menu_enabled, vertical_menu_left, vertical_menu_width_290,smooth_scroll,side_menu_slide_from_right,blog_installed,wpb-js-composer js-comp-ver-5.2,vc_responsive

European Patients’ Forum-Medicines for Europe

Ovidiu Constantinescu, Chairman of the Board of AGORA: “The patient should be an active and equal partner when any new health legislation is drafted. Placing the patient at the center of the health system also means rapid and unrestricted access to effective medication and treatments and this should be at the heart of the new EU Parliament activities”

AGORA’s Chairman of the Board, Mr. Ovidiu Constantinescu, attended the fourth edition of the annual dialogue organized by the European Patients’ Forum-Medicines for Europe that was held in Brussels on the 25th of October 2019.
Amid the appointment of a new European Commission and a new EU legislative body following the May EU elections, the debate focused on key health policy priorities that should be at the core of the legislative debate in Europe.
Ovidiu Constantinescu, Chairman of the Board of AGORA: “The patient should be an active and equal partner when any new health legislation is drafted. Placing the patient at the center of the health system also means rapid and unrestricted access to effective medication and treatments and this should be at the heart of the new EU Parliament activities. When talking about cost-effectiveness of a certain medication or treatment, the emphasis should be placed on <effectiveness>. Added to that, one should take advantage of all the opportunities in order to insure access to affordable medication.”
Over 25 patient organizations’ representatives, experts as well as Medicines for Europe and EPF representatives joined the debates that have been moderated by Adrian van Hoven – Medicines for Europe’s Director General, and Usman Khan – European Patients’ Forum’s Executive Director.
The debates focused on: digital solutions for patients with value added medicines; generic medication; patient perspectives on biosimilar medicines; medicines shortages, routes to finding solutions. The general conclusion of the organizers was that “discussions were fruitful and interesting, opening lots of opportunities for future collaboration”.

 

0 Comments
Share Post
No Comments

Sorry, the comment form is closed at this time.